Oragenics Inc (NYSEAMERICAN:OGEN) shares shot up 1.8% on Friday . The stock traded as high as $0.59 and last traded at $0.56, 62,634 shares traded hands during mid-day trading. A decline of 95% from the average session volume of 1,174,844 shares. The stock had previously closed at $0.55.
Separately, HC Wainwright set a $2.00 price target on shares of Oragenics and gave the stock a “buy” rating in a research report on Friday, August 16th.
Oragenics (NYSEAMERICAN:OGEN) last announced its quarterly earnings results on Wednesday, August 14th. The biotechnology company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.03).
About Oragenics (NYSEAMERICAN:OGEN)
Oragenics, Inc develops novel antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients.
Featured Article: How to Invest in Stocks with Increasing Dividends
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.